0059 GMT - Ansell's sales volumes could be at risk from lower demand amid slower economic growth, Morgan Stanley analyst David L. Bailey writes in a note. While the personal-protective equipment maker has said it will offset the impact of tariffs through higher pricing, Bailey no longer expects revenue to grow at Ansell's industrial business in fiscal 2026 or fiscal 2027. He forecasts a 1% decline in industrial revenue in both years, having previously expected 4% growth in each. The healthcare unit is less exposed, but Bailey trims his overall EPS forecasts for fiscal 2026 and 2027 by 9% and 11%, respectively. MS cuts its target price 10% to A$33.40 and stays equal-weight on the stock. Shares are down 0.9% at A$29.435. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
April 13, 2025 20:59 ET (00:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。